Influenza, SARS-CoV-2 and RSV activity in EU/EEA Member States continue to decrease or remain stable at low levels. Cases, including severe infections, can still occur and it therefore remains essential to continue testing patients presenting with severe acute respiratory symptoms in order to guide treatment and inform epidemiological assessments.
In 2014, a total of 16 cases of anthrax was reported by four EU/EEA countries. One case was reported as a confirmed case. The remaining 26 reporting countries notified zero cases.